Virtus' Management team has considerable experience in the Assisted Reproductive Services (ARS), diagnostics and day hospital markets around the world.
Sue Channon, Group CEO
Sue has held senior management positions in various Australian healthcare organisations for over 20 years. Before her appointment to CEO of Virtus in November 2010, Sue was CEO of IVF Australia Pty Ltd. Prior to joining Virtus, Sue was State Manager for NSW and ACT for Medical Imaging Australia, the National Director of Nursing for Mayne Group (now part of Ramsay Health Care), CEO of Kareena Private Hospital, CEO of Castlecrag and Mosman Private Hospital and CEO and Director of Nursing for Castlecrag Private Hospital.
Sue is a member of the Risk Committee.
Glenn Powers, CFO and Company Secretary
Glenn joined Virtus as CFO and Company Secretary in August 2008. Prior to joining Virtus, Glenn was CFO and Company Secretary of Tower Software Limited.
Glenn has a broad range of experience in private equity backed businesses, working in a range of engineering, electronics, software and service businesses. Glenn has also been a Director for both main and AIM market listed businesses in the UK. Glenn is a Chartered Management Accountant.
Teena Pisarev, Managing Director, NSW
Teena is an experienced executive, with a demonstrated history of working in the hospital & health care industry.
Skilled in strategic planning, business development, strategy, change management, and healthcare management, Teena has 23 years’ experience working across leadership roles managing the delivery of clinical services.
A strong business development professional, Teena graduated from Griffith University (AUS).
A/Prof Peter Illingworth, Medical Director, New South Wales
Peter joined Virtus in May 2006 and since that date has served as Medical Director of IVF Australia Pty Ltd along with providing contracted clinical services to patients of IVF Australia Pty Ltd.
Peter is an accredited specialist obstetrician and gynaecologist with over 20 years specialist experience in the area of infertility practice. Peter has an international reputation in the field of reproductive medicine.
Prior to joining Virtus, Peter was Network Director at the Women’s and Children’s Health, Director of Reproductive Medicine at Westmead Hospital and a Clinical Scientist at MRC Reproductive Biology Unit in Edinburgh, Scotland.
Peter is a Conjoint Honorary Associate Professor at Sydney University, a position he has held since 1996.
Jade Phelan, Managing Director, Victoria & Tasmania
Jade is a highly regarded healthcare executive with a unique combination of significant operational experience gained from managing in a large and complex private hospital environment and strong commercial acumen having begun her career in finance roles with two major accounting firms.
Jade worked at Healthscope Operations Limited for six years as the CEO of The Mount Private Hospital in WA, one of the largest Healthscope hospitals in the country, before returning home to Melbourne and commencing with Virtus in late 2016.
With a strong track record of thriving in a patient and doctor facing environment in specialist healthcare, Jade is a welcomed member of the executive team.
Dr Lyndon Hale, Medical Director, Victoria
Lyndon has been the Medical Director of Melbourne IVF Pty Ltd since 2008. He is also Director of Reproductive Surgery at The Women’s Hospital, and is on the board of the Fertility Society of Australia. Lyndon is highly regarded for his knowledge and proactive approach and brings extensive experience in assisted reproduction treatments to the care of his patients.
Dr Bill Watkins, Medical Director, Tasmania
Bill is currently Clinical Director of TasIVF, having been part of the TasIVF team since 1996. He is also the only CREI qualified fertility specialist in Tasmania. Bill was Senior Registrar at the Royal Women’s Hospital in Melbourne from 1993 until early 1996, where he was responsible for the IVF program and involved in establishing one of Australia’s first ICSI programs. He returned to Tasmania in 1996 and joined TasIVF, initially established as one of Australia's first IVF clinics by three gynaecoligists, including Bill's father.
Steve Zappia, Managing Director, Queensland and Virtus Diagnostics
Steve joined Virtus in May 2013. Prior to joining Virtus, Steve amassed a wealth of experience in the health industry having served as State Manager Queensland for Primary Healthcare, National Laboratory Manager for Idexx, General Manager Queensland and Practice Group Manager for Imed, General Manager Pathology and Development Manager for MIA and State Operations Manager NSW for Mayne Health. Steve also has extensive experience as a pathology scientist.
A/Prof Anusch Yazdani, Medical Director, Queensland
A/Prof Anusch Yazdani was appointed the Medical Director of Queensland Fertiity Group in 2019. He is a graduate of the University of Queensland (MBBS Hons), Anusch completed his specialisation in Obstetrics and Gynaecology (FRANZCOG) in Brisbane.
Following a fellowship in minimally invasive pelvic surgery in Sydney, A/Prof Yazdani returned to Brisbane in 2002 to develop tertiary referral units in minimally invasive surgery at the Royal Brisbane and Mater Hospitals. In 2006, he completed his subspecialisation in Reproductive Endocrinology and Infertility (CREI), resulting in the unique subspecialist qualifications in reproductive endocrinology, fertility and minimally invasive surgery.
A/Prof Yazdani is widely published in medical journals, has co-authored numerous textbooks and lectures widely nationally and internationally.
Dr David Molloy, Director Medical Affairs, Virtus Health
David was appointed as Director Medical Affairs in 2019 to identify and proactively manage Virtus Health's interests within the political, legislative and regulatory environment in which the ARS sector operates in Australia.
Serving as Medical Director of Queensland Fertility Group Pty Ltd in 2004 and providing contracted clinical services to patients of Queensland Fertility Group Pty Ltd since 1986, David has a distinguished resume of achievements, including acting as President of the Australian Medical Association in Queensland, Australian Gynaecological Endoscopy & Surgery Society Limited and National Association of Specialist Obstetricians and Gynaecologists as well as Chairman of the IVF Directors Group.
David also currently holds the position of Vice Chair of the IVF Directors Group, a position he has held since 2004.
Richard Banks, Managing Director, Europe
Richard joined Virtus in August 2017 with a strong reputation in strategic planning, service transformation, operational turnaround, business development and program management. Richard has significant experience of working with Executive teams in healthcare organisations and enjoys both developing strategy and taking plans through to implementation.
Richard received his formal management training through the UK’s NHS Graduate Management Training Scheme and he has a Master’s degree in Healthcare Management and Leadership. He has worked as an NHS Director, Management Consultant and Private Hospital Director. Richard is a Fellow of the Chartered Management Institute and the Institute of Leadership and Management.
Richard plays a vital role in the expansion of Virtus operations within Europe.
Dr John Kennedy, Medical Director, Ireland
John was appointed Medical Director of the Virtus Sims Group in July 2017. In his role, John is responsible for Virtus Health’s full Irish medical team, leading and directing his team on all medical and clinical matters and all related communications.
John is also the appointed Responsible Person “RP” for all three Irish Clinics, a critical element of Virtus’ Irish operation.
Graduating from University College Dublin in 2000, John is a member of the Royal College of Physicians, Ireland. Prior to joining Sims as a consultant in 2013, John practised Obstetrics and Gynaecology throughout the Dublin maternity hospitals and has extensive experience in all aspects of his specialist field.
Dr Bjørn Bay, Medical Director, Aagaard Klinik
Joining Virtus in January 2020 as Medical Director Bjorn is a Medical Doctor and PhD with a special interest in assisted reproduction. Most recently Bjørn was a specialist IVF doctor at the regional Hospital Horsens Fertility Clinic which amalgamated with the Fertility Clinic at Aarhus University Hospital in 2016.
Bjorn has a special focus on the safety of the procedures and on selection, screening and safety of semen donations having been MD and Medical Director of Cyros International for a decade. Bjorn undertook specialist training at Aarhus University originally before post doctorate studies with the Centre for Family Research at University of Cambridge.
Dr Kåre Rygaard, Medical Director, Trianglen Denmark
Kåre is the Medical Director of Trianglen Fertility Clinic in Copenhagen. Partnering with the Virtus Health group in June 2018, Kåre is a specialist in advanced infertility treatment and all procedures related to infertility including IUI, IVF, ICSI and TESA.
Kåre first joined Trianglen Fertility Clinic as an external consultant in 2001. In 2005, he accepted a full-time position at the clinic and in 2012 became the owner of Trianglen.
Kåre studied medicine at the University of Copenhagen, graduating in 1987. Completing his thesis in 1993, Kåre undertook laboratory research on cancer related genes in small cell lung before becoming a specialist in obstetrics and gynaecology in 2000. Fascinated by the field of fertility, Kåre obtained further education from the fertility clinics at Rigshospitalet and Herlev Hospital, both of which are part of The Copenhagen University Hospital.
Professor Ying Cheong, Medical Director, Complete Fertility
Medical Director and Co-founder Complete Fertility is a Professor of Reproductive Medicine at the University of Southampton, a specialist in Fertility Medicine, laparoscopic and open fertility surgery, endometriosis, recurrent miscarriage, polycystic ovarian disease and adhesions.
Prof Ying is an active researcher, leading the clinical research network for Reproductive Health in Hampshire and Isle of Wight and, lectures around the world disseminating her research as editor and author to over 100 peer-reviewed papers, books and chapters. An educator of Undergraduate and Post-graduate medicine and other related biological sciences she continues to mentor clinicians of the future. In her daily practice, Prof Ying cares for both private and NHS patients.
Raju Narayan, Managing Director, Singapore
Raju joined Virtus in 2013, where he led business development in the Asia Pacific and Middle East regions, before opening Virtus’ first fertility clinic in Asia in late 2014. Raju has over 25 years’ experience in the management and development of public and private hospitals in Singapore, India, the broader South-East Asian region and the Middle East. Prior to joining Virtus, Raju served as the CEO of Parkway East Hospital, Singapore and as the Divisional President, International Operations for Parkway Group Healthcare. Raju was the Executive director of the Board for Parkway Group’s joint ventures in India, Abu Dhabi and Vietnam. He has held various senior management positions at Singaporean hospitals including Tan Tock Seng, Changi General and Raffles Hospital throughout his healthcare career.
Dr Ann Tan, Medical Director, Singapore
Dr Ann Tan brings a wealth of experience to the Virtus Group as the Medical Director of Virtus Fertility Centre Singapore and is responsible for the high level of medical standards, laboratory operations and treatment quality the centre provides.
Dr Tan has been the recipient of several prestigious awards in her field of specialization including the HMDP Scholarship for Fetal Echocardiography at Yale School of Medicine in 1995, the Young Investigator Award by the International Society of Ultrasound in Obstetrics & Gynaecology in 1995 and the Young Investigator Award at the International Scientific Meeting of Royal College of Obstetricians & Gynaecologists in 1993. She was also awarded the Public Service Medal for her contributions with the Singapore Council of Women’s Organisations in 2012. Dr Ann Tan has an interest in research focused on in optimising fertility and ovarian reserves.